The Role of Tocilizumab in Glucocorticoid Resistant Giant Cell Arteritis: A Case Series and Literature Review: Erratum

Erratum Erratum The Role of Tocilizumab in Glucocorticoid Resistant Giant Cell Arteritis: A Case Series and Literature Review: Erratum In the March 2023 issue of Journal of Neuro-Ophthalmology (vol. 43, no. 1), the Methods section of the Abstract read “(TAB) negative,” but it should have read “(TAB)-positive.” The corrected sentence is included below. We present a literature review on tocilizumab as rescue therapy and a retrospective case series of 5 consecutive glucocorticoid (GC)-resistant, temporal artery biopsy (TAB)-positive patients. REFERENCE 1. Stretton B, Tan Y, Hassall M, Simon S. The role of tocilizumab in glucocorticoid resistant giant cell arteritis: a case series and literature review. J Neuroophthalmol. 2023;43:91–95. Stretton et al: J Neuro-Ophthalmol 2023; 43: e97 e97 Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited.